Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma

Junko Hamamoto, Kenzo Soejima, Satoshi Yoda, Katsuhiko Naoki, Sohei Nakayama, Ryosuke Satomi, Hideki Terai, Shinnosuke Ikemura, Takashi Sato, Hiroyuki Yasuda, Yuichiro Hayashi, Michiie Sakamoto, Toru Takebayashi, Tomoko Betsuyaku

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Recent advances in the treatment of non-small cell lung cancer (NSCLC) with new agents require accurate histological subtyping at diagnosis to avoid the higher risk of an adverse response and to obtain the maximum therapeutic response. However, interobserver variability, tumor heterogeneity and the degree of differentiation may affect the decision concerning a pathological diagnosis of NSCLC. Therefore, the aim of this study was to identify specific microRNAs (miRNAs) as standardized biomarkers with high sensitivity and specificity in order to distinguish between squamous cell carcinoma (SCC) and adenocarcinoma (AC). Quantitative polymerase chain reaction (qPCR)-based miRNA array analysis was performed to identify microRNAs differentially expressed between SCC and AC using 86 resected NSCLC samples in addition to adjacent normal tissues. The results were confirmed by independent qRT-PCR assays with the same test samples and 88 additional validation samples, and from this we evaluated the usefulness of the identified miRNAs as biomarkers to distinguish between SCC and AC. Three miRNAs (hsa-miR-196b, hsa-miR-205 and hsa-miR-375) were identified. Discriminant analysis combining the three miRNAs appeared to distinguish SCC from AC accurately in the test and validation samples, demonstrating a sensitivity and specificity of 76 and 80%, and 85 and 83%, respectively. hsa-miR-196b, hsa-miR-205 and hsa-miR-375 were identified as biomarkers capable of distinguishing between lung SCC and lung AC. These newly identified miRNAs may prove to be highly valuable molecular markers for the classification of NSCLC histological subtypes and may contribute to the pathogenesis of each subtype of NSCLC.

Original languageEnglish
Pages (from-to)456-462
Number of pages7
JournalMolecular Medicine Reports
Volume8
Issue number2
DOIs
Publication statusPublished - 2013 Aug

Fingerprint

MicroRNAs
Squamous Cell Carcinoma
Non-Small Cell Lung Carcinoma
Lung
Adenocarcinoma
Biomarkers
Sensitivity and Specificity
Polymerase Chain Reaction
Observer Variation
Polymerase chain reaction
Discriminant Analysis
Discriminant analysis
Adenocarcinoma of lung
Epithelial Cells
Tumors
Assays
Cells
Tissue
Neoplasms

Keywords

  • Adenocarcinoma
  • Biomarker
  • Lung cancer
  • MicroRNA
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Biochemistry
  • Cancer Research
  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Oncology

Cite this

Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. / Hamamoto, Junko; Soejima, Kenzo; Yoda, Satoshi; Naoki, Katsuhiko; Nakayama, Sohei; Satomi, Ryosuke; Terai, Hideki; Ikemura, Shinnosuke; Sato, Takashi; Yasuda, Hiroyuki; Hayashi, Yuichiro; Sakamoto, Michiie; Takebayashi, Toru; Betsuyaku, Tomoko.

In: Molecular Medicine Reports, Vol. 8, No. 2, 08.2013, p. 456-462.

Research output: Contribution to journalArticle

Hamamoto, Junko ; Soejima, Kenzo ; Yoda, Satoshi ; Naoki, Katsuhiko ; Nakayama, Sohei ; Satomi, Ryosuke ; Terai, Hideki ; Ikemura, Shinnosuke ; Sato, Takashi ; Yasuda, Hiroyuki ; Hayashi, Yuichiro ; Sakamoto, Michiie ; Takebayashi, Toru ; Betsuyaku, Tomoko. / Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. In: Molecular Medicine Reports. 2013 ; Vol. 8, No. 2. pp. 456-462.
@article{ad3e6db8b770477bb2962dc89e36f806,
title = "Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma",
abstract = "Recent advances in the treatment of non-small cell lung cancer (NSCLC) with new agents require accurate histological subtyping at diagnosis to avoid the higher risk of an adverse response and to obtain the maximum therapeutic response. However, interobserver variability, tumor heterogeneity and the degree of differentiation may affect the decision concerning a pathological diagnosis of NSCLC. Therefore, the aim of this study was to identify specific microRNAs (miRNAs) as standardized biomarkers with high sensitivity and specificity in order to distinguish between squamous cell carcinoma (SCC) and adenocarcinoma (AC). Quantitative polymerase chain reaction (qPCR)-based miRNA array analysis was performed to identify microRNAs differentially expressed between SCC and AC using 86 resected NSCLC samples in addition to adjacent normal tissues. The results were confirmed by independent qRT-PCR assays with the same test samples and 88 additional validation samples, and from this we evaluated the usefulness of the identified miRNAs as biomarkers to distinguish between SCC and AC. Three miRNAs (hsa-miR-196b, hsa-miR-205 and hsa-miR-375) were identified. Discriminant analysis combining the three miRNAs appeared to distinguish SCC from AC accurately in the test and validation samples, demonstrating a sensitivity and specificity of 76 and 80{\%}, and 85 and 83{\%}, respectively. hsa-miR-196b, hsa-miR-205 and hsa-miR-375 were identified as biomarkers capable of distinguishing between lung SCC and lung AC. These newly identified miRNAs may prove to be highly valuable molecular markers for the classification of NSCLC histological subtypes and may contribute to the pathogenesis of each subtype of NSCLC.",
keywords = "Adenocarcinoma, Biomarker, Lung cancer, MicroRNA, Squamous cell carcinoma",
author = "Junko Hamamoto and Kenzo Soejima and Satoshi Yoda and Katsuhiko Naoki and Sohei Nakayama and Ryosuke Satomi and Hideki Terai and Shinnosuke Ikemura and Takashi Sato and Hiroyuki Yasuda and Yuichiro Hayashi and Michiie Sakamoto and Toru Takebayashi and Tomoko Betsuyaku",
year = "2013",
month = "8",
doi = "10.3892/mmr.2013.1517",
language = "English",
volume = "8",
pages = "456--462",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma

AU - Hamamoto, Junko

AU - Soejima, Kenzo

AU - Yoda, Satoshi

AU - Naoki, Katsuhiko

AU - Nakayama, Sohei

AU - Satomi, Ryosuke

AU - Terai, Hideki

AU - Ikemura, Shinnosuke

AU - Sato, Takashi

AU - Yasuda, Hiroyuki

AU - Hayashi, Yuichiro

AU - Sakamoto, Michiie

AU - Takebayashi, Toru

AU - Betsuyaku, Tomoko

PY - 2013/8

Y1 - 2013/8

N2 - Recent advances in the treatment of non-small cell lung cancer (NSCLC) with new agents require accurate histological subtyping at diagnosis to avoid the higher risk of an adverse response and to obtain the maximum therapeutic response. However, interobserver variability, tumor heterogeneity and the degree of differentiation may affect the decision concerning a pathological diagnosis of NSCLC. Therefore, the aim of this study was to identify specific microRNAs (miRNAs) as standardized biomarkers with high sensitivity and specificity in order to distinguish between squamous cell carcinoma (SCC) and adenocarcinoma (AC). Quantitative polymerase chain reaction (qPCR)-based miRNA array analysis was performed to identify microRNAs differentially expressed between SCC and AC using 86 resected NSCLC samples in addition to adjacent normal tissues. The results were confirmed by independent qRT-PCR assays with the same test samples and 88 additional validation samples, and from this we evaluated the usefulness of the identified miRNAs as biomarkers to distinguish between SCC and AC. Three miRNAs (hsa-miR-196b, hsa-miR-205 and hsa-miR-375) were identified. Discriminant analysis combining the three miRNAs appeared to distinguish SCC from AC accurately in the test and validation samples, demonstrating a sensitivity and specificity of 76 and 80%, and 85 and 83%, respectively. hsa-miR-196b, hsa-miR-205 and hsa-miR-375 were identified as biomarkers capable of distinguishing between lung SCC and lung AC. These newly identified miRNAs may prove to be highly valuable molecular markers for the classification of NSCLC histological subtypes and may contribute to the pathogenesis of each subtype of NSCLC.

AB - Recent advances in the treatment of non-small cell lung cancer (NSCLC) with new agents require accurate histological subtyping at diagnosis to avoid the higher risk of an adverse response and to obtain the maximum therapeutic response. However, interobserver variability, tumor heterogeneity and the degree of differentiation may affect the decision concerning a pathological diagnosis of NSCLC. Therefore, the aim of this study was to identify specific microRNAs (miRNAs) as standardized biomarkers with high sensitivity and specificity in order to distinguish between squamous cell carcinoma (SCC) and adenocarcinoma (AC). Quantitative polymerase chain reaction (qPCR)-based miRNA array analysis was performed to identify microRNAs differentially expressed between SCC and AC using 86 resected NSCLC samples in addition to adjacent normal tissues. The results were confirmed by independent qRT-PCR assays with the same test samples and 88 additional validation samples, and from this we evaluated the usefulness of the identified miRNAs as biomarkers to distinguish between SCC and AC. Three miRNAs (hsa-miR-196b, hsa-miR-205 and hsa-miR-375) were identified. Discriminant analysis combining the three miRNAs appeared to distinguish SCC from AC accurately in the test and validation samples, demonstrating a sensitivity and specificity of 76 and 80%, and 85 and 83%, respectively. hsa-miR-196b, hsa-miR-205 and hsa-miR-375 were identified as biomarkers capable of distinguishing between lung SCC and lung AC. These newly identified miRNAs may prove to be highly valuable molecular markers for the classification of NSCLC histological subtypes and may contribute to the pathogenesis of each subtype of NSCLC.

KW - Adenocarcinoma

KW - Biomarker

KW - Lung cancer

KW - MicroRNA

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84879983640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879983640&partnerID=8YFLogxK

U2 - 10.3892/mmr.2013.1517

DO - 10.3892/mmr.2013.1517

M3 - Article

C2 - 23759980

AN - SCOPUS:84879983640

VL - 8

SP - 456

EP - 462

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 2

ER -